Status:

UNKNOWN

Pilot Study: Geniculate Artery Embolization in Knee Osteoarthrosis.

Lead Sponsor:

Maisonneuve-Rosemont Hospital

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Geniculate Artery Embolization (GAE) has recently been described and studied as a palliative treatment for osteoarthrosis-related knee pain in patients un-eligible for surgical intervention. This trea...

Detailed Description

Primary Objective Confirm the efficacy and the effectiveness of geniculate artery embolization for pain control in knee osteoarthrosis. Secondary Objective Evaluate the effectiveness of geniculate ar...

Eligibility Criteria

Inclusion

  • 18 years and older
  • Moderate to severe knee pain (visual analog scale (VAS) \> 70 mm)
  • Pain refractory to at least 6 months of conservative therapies (anti-inflammatory drugs, or physical therapy, or muscle strengthening, or intra-articular injections)
  • Localized pain on physical examination
  • Kellgren-Lawrence (KL) Score on knee X-Ray
  • Patients 50 years old and over : grade 1, 2, 3 or 4
  • 18-50 years old: KL grade 3 or 4

Exclusion

  • Current local infection
  • Life expectancy less than 6 months
  • Known advanced atherosclerosis
  • Rheumatoid or infectious arthritis
  • Prior knee surgery
  • Uncorrectable coagulopathy including international normalized ratio (INR) \> 1.5 or platelets \< 50,000
  • Iodine allergy
  • Renal dysfunction as defined by GFR \< 60ml/min obtained within the past 30 days.
  • Diabetic patient
  • Previous embolization of the geniculate arteries during the last year

Key Trial Info

Start Date :

February 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04113681

Start Date

February 14 2019

End Date

December 31 2021

Last Update

March 8 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CIUSSS de l'Est-de-l'Île-de-Montréal, Installation Hopital Maisonneuve-Rosemont

Montreal, Quebec, Canada, H1T 2M4